Qiyun Shao

This inventor holds 8 USPTO granted patents and 8 published patent applications and 3 EPO patents. Top assignees: Jiangsu Hengrui Medicine Company Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qiyun Shao. Retrieved from https://idiyas.com/inventor/qiyun-shao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 8)

% Patents Active = 75.0

EPO Patents = 3 (Patent Applications = 16)

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 2(Granted Patents)

Location History:

Shanghai, CN (2021 - 2022)
Jiangsu, CN (2021 - 2022)

Company Filing History:

8 out of 159

Jiangsu Hengrui Medicine Company Ltd.

patents

4 out of 100

Shanghai Hengrui Pharmaceutical Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 2021-2026

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE51039 - Crystal of benzofuran derivative free base and preparation method (2026-09-22),

2. 12269823 - Crystal form of pyridopyrimidine derivative and preparation method thereof (2025-04-08),

3. 11390614 - Method for preparing benzofuran derivative (2022-07-19),

4. 11299462 - Crystal form of oxopicolinamide derivative and preparation method therefor (2022-04-12),

5. 11225462 - Crystal forms of oxypyridine amide derivative and preparation method therefor (2022-01-18),

6. 11180530 - Salt of phenylpropionamide derivative and preparation method therefor (2021-11-23),

7. 11155537 - Crystal of benzofuran derivative free base and preparation method (2021-10-26),

8. 11059810 - Pharmaceutically acceptable salt as renal outer medullary potassium channel inhibitor (2021-07-13),

Title: The Innovative Mind of Qiyun Shao

Introduction

Qiyun Shao is an accomplished inventor based in Shanghai, China, known for his significant contributions to the field of pharmaceuticals. With a total of seven patents to his name, Shao's work focuses on the development of innovative compounds and preparation methods that enhance therapeutic effectiveness.

Latest Patents

Among his latest patents is the "Crystal form of pyridopyrimidine derivative and preparation method thereof." This disclosure relates specifically to a new crystal form of a pyridopyrimidine derivative, which showcases improved physical and chemical properties, ultimately facilitating clinical treatments. Another notable patent is the "Method for preparing benzofuran derivative," which offers a streamlined approach to synthesizing benzofuran substances, effectively shortening the reaction steps compared to prior art.

Career Highlights

Qiyun Shao has made his mark in the pharmaceutical industry by working with prominent companies such as Jiangsu Hengrui Medicine Company Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd. These roles allowed him to apply his innovative thinking and expertise in the development of crucial medical compounds.

Collaborations

Throughout his career, Shao has collaborated with esteemed colleagues, including Jun Feng and Feng He. These partnerships have enabled him to broaden the impact of his research and innovations in the pharmaceutical field.

Conclusion

Qiyun Shao stands out as a remarkable inventor with a focus on advancing pharmaceutical technologies. His multiple patents reflect his commitment to facilitating clinical advancements through innovative solutions. As he continues to contribute to this vital field, his work promises to enhance patient care and treatment outcomes in the future.

Profile summary based on public USPTO records.